What about zero-calorie sweeteners
Constantinescu et al., 2012), CBD (Constantinescu et al., 2012), and PDD (Hall et al., 2012)
Side Effects & Safety Mild GI discomfort most common, usually transient in the first week Slight stimulant effect increased energy/alertness, especially early on Headaches occasional, typically mild and dose-related Mild insomnia if taken too late in the day No human clinical safety data all safety information from preclinical studies and community reports No liver toxicity observed in animal studies at therapeutic doses Unknown drug interactions theoretically could interact with NAD+-dependent pathways Core Supplies for This Protocol The essentials for running any reconstituted injectable: cold storage, accurate syringes, alcohol prep pads, and metabolic tracking
What Science Says About Your Risk
We know that everyone has different medical needs and that some therapies offered through their doctor may not be the best fit for them